Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy

DOI: 10.3349/ymj.2019.60.1.30

Keywords: UGT2B7, polymorphism, chemotherapy, cardiotoxicity, breast cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text